EDMONTON, Alberta, Dec. 11 /PRNewswire-FirstCall/ -- Medical Services International Inc (Pink Sheets: MSITF) predicts that revenues will exceed 4.0 million US in the second half (January 2008 to June 2008) of its fiscal year. The predicted revenues are based on existing contracts and do not take into account the internet sales that the Company expects in the second half.
As well as its existing products, the company has developed several new products that will be available on its internet site early in March, 2008. These products have been developed inhouse and have had extensive testing. The delay in bringing them to market is that the company is working to submit them for the necessary patents so that these products are protected from competitors. These products are based on all natural ingredients, there are no synthetic ingredients whatsoever. These products will initially only be available through the internet site. However the company is negotiating with several retail outlets for them to carry the products. The demand for these products is expected to be exceptional
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer.
Medical Services International Inc trades in the United States on the NQB Pink Sheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com or http://www.minerva-biotech.com
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially.
Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
|SOURCE Medical Services International Inc.|
Copyright©2007 PR Newswire.
All rights reserved